A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease.
DIABETES & METABOLISM JOURNAL（2024）
Key words
human,Biomarkers,Keratin-18,Magnetic resonance imaging,Non-alcoholic fatty liver disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined